We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search

Clear all

Refine your search

Tags

Firm name

Author

6,099 results found

Article

Loeb & Loeb LLP | USA | 15 Jul 2019

At a Glance: Decision of the U.S. District Court for the District of Columbia for Merck & Co., Inc., et al. v. United States Department of Health and Human Services

Decision of the U.S. District Court for the District of Columbia: i) confirming that the Department of Health & Human Services has no statutory

Article

McGuireWoods Consulting LLC | USA | 12 Jul 2019

NCGA Week in Review- Jul 12, 2019

From healthcare to hemp, members of the North Carolina General Assembly pushed through another week of long floor sessions and packed committee

Article

Littler Mendelson PC | USA | 11 Jul 2019

HHS Proposed Regulations Remove Protections from the Affordable Care Act for Transgender Patients

On May 24, 2019, the U.S. Department of Health and Human Services (HHS) issued new proposed regulations interpreting Section 1557 of the Affordable

Article

Frankfurt Kurnit Klein & Selz PC | USA | 10 Jul 2019

Court Vacates HHS Rule Requiring Disclosure of Drug Prices in Television Commercials

In May, we reported that the United States Department of Health and Human Services finalized a new rule that requires most television commercial

Article

Quarles & Brady LLP | USA | 9 Jul 2019

340B Litigation Updates and Other Program Developments

In the latest development of the ongoing 340B Medicare Part B payment reduction controversy, US District Judge Rudolph Contreras again concluded that

Article

Kelley Drye & Warren LLP | USA | 8 Jul 2019

Senator Wyden Again Urges FDA to Clarify CBD Pathway; Agency Extends Comment Deadline and Issues New Communications

On June 25, 2019, Senator Ron Wyden (D-OR) issued a letter urging Department of Health and Human Services (HHS) Secretary Alex Azar and Food and Drug

Article

Morgan Lewis | USA | 2 Jul 2019

Will Hospitals and Insurers Have to Disclose Their Contracted Rates to Consumers Under Executive Order?

US President Donald Trump issued the Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First on June

Article

Winston & Strawn LLP | USA | 2 Jul 2019

Health Care Price Transparency: Reality or Mirage?

On June 24, 2019, President Trump signed the Executive Order on Improving Price and Quality Transparency in American Healthcare to Put Patients First

Article

Frost Brown Todd LLC | USA | 1 Jul 2019

Trump issues Executive Order to improve quality and price transparency

President Trump issued an Executive Order directing multiple federal agencies to develop regulations with the goal of enhancing consumers’ ability to

Article

Nexsen Pruet | USA | 1 Jul 2019

The Cost of Cost Transparency for Hospitals

As healthcare reform continues to be a dividing issue in Washington, both sides seem to agree on at least one element: price transparency. Trump’s